BioCentury | Apr 23, 2012
Clinical News

KeyPath MRSA/MSSA Blood Culture Test-BT regulatory update

...granted 510(k) clearance to include the use of 4 BD Bactec blood culture bottles for Microphage's...
...rights, markets the product in the U.S. The blood culture test has CE Mark approval. Microphage Inc....
BioCentury | Oct 17, 2011
Company News

Cardinal Health, Microphage sales and marketing update

...and has CE Mark approval (see BioCentury, May 16). Cardinal Health Inc. (NYSE:CAH), Dublin, Ohio MicroPhage Inc....
BioCentury | May 16, 2011
Clinical News

KeyPath MRSA/MSSA Blood Culture Test regulatory update

...FDA granted 510(k) clearance to Microphage's KeyPath MRSA/MSSA Blood Culture Test to identify Staphylococcus aureus bacteria...
...uses MicroPhage's bacteriophage amplification platform, is marketed outside the U.S. and has CE Mark approval. Microphage Inc....
BioCentury | Feb 14, 2011
Company News

Microphage management update

Microphage Inc. , Longmont, Colo. Business: Diagnostic Hired: Don Mooney as CEO, formerly president and CEO of ProteoGenix Inc. ; he replaces interim CEO Drew Smith, who will remain CSO WIR Staff Diagnostic...
BioCentury | May 31, 2010
Company News

Microphage sales and marketing update

...MicroPhage launched its Microphage MRSA/MSSA blood culture test outside the U.S. to identify Staphylococcus aureus bacteria...
...which uses MicroPhage's bacteriophage amplification platform and is already CE marked (see BioCentury, March 15). MicroPhage Inc....
BioCentury | Apr 5, 2010
Company News

AspenBio management update

...Business: Veterinary, Diagnostic, Supply/Service Hired: Steve Lundy as CEO and a director, formerly CEO of MicroPhage Inc....
BioCentury | Mar 29, 2010
Company News

Microphage management update

MicroPhage Inc. , Longmont, Colo. Business: Diagnostic Promoted: Alene Campbell to CEO from COO; she replaces Steve Lundy, who resigned WIR Staff...
BioCentury | Mar 15, 2010
Clinical News

MRSA/MSSA blood culture test regulatory update

...MicroPhage submitted a 510(k) application to FDA for its Microphage MRSA/MSSA blood culture test to identify...
...cases of bacteremia. The test, which uses MicroPhage's bacteriophage amplification platform, is already CE marked. Microphage Inc....
BioCentury | Dec 14, 2009
Clinical News

MRSA/MSSA blood culture test regulatory update

...aureus bacteria and determine methicillin resistance (MRSA) or susceptibility (MSSA) in suspected cases of bacteremia. Microphage...
...of the test in August designed to support a 510(k) application (see BioCentury, Aug. 31). Microphage Inc....
BioCentury | Aug 31, 2009
Clinical News

MRSA/MSSA blood culture test: Pivotal trial started

...a U.S. pivotal trial to evaluate its MRSA/MSSA blood culture test in about 700 patients. Microphage Inc....
Items per page:
1 - 10 of 11
BioCentury | Apr 23, 2012
Clinical News

KeyPath MRSA/MSSA Blood Culture Test-BT regulatory update

...granted 510(k) clearance to include the use of 4 BD Bactec blood culture bottles for Microphage's...
...rights, markets the product in the U.S. The blood culture test has CE Mark approval. Microphage Inc....
BioCentury | Oct 17, 2011
Company News

Cardinal Health, Microphage sales and marketing update

...and has CE Mark approval (see BioCentury, May 16). Cardinal Health Inc. (NYSE:CAH), Dublin, Ohio MicroPhage Inc....
BioCentury | May 16, 2011
Clinical News

KeyPath MRSA/MSSA Blood Culture Test regulatory update

...FDA granted 510(k) clearance to Microphage's KeyPath MRSA/MSSA Blood Culture Test to identify Staphylococcus aureus bacteria...
...uses MicroPhage's bacteriophage amplification platform, is marketed outside the U.S. and has CE Mark approval. Microphage Inc....
BioCentury | Feb 14, 2011
Company News

Microphage management update

Microphage Inc. , Longmont, Colo. Business: Diagnostic Hired: Don Mooney as CEO, formerly president and CEO of ProteoGenix Inc. ; he replaces interim CEO Drew Smith, who will remain CSO WIR Staff Diagnostic...
BioCentury | May 31, 2010
Company News

Microphage sales and marketing update

...MicroPhage launched its Microphage MRSA/MSSA blood culture test outside the U.S. to identify Staphylococcus aureus bacteria...
...which uses MicroPhage's bacteriophage amplification platform and is already CE marked (see BioCentury, March 15). MicroPhage Inc....
BioCentury | Apr 5, 2010
Company News

AspenBio management update

...Business: Veterinary, Diagnostic, Supply/Service Hired: Steve Lundy as CEO and a director, formerly CEO of MicroPhage Inc....
BioCentury | Mar 29, 2010
Company News

Microphage management update

MicroPhage Inc. , Longmont, Colo. Business: Diagnostic Promoted: Alene Campbell to CEO from COO; she replaces Steve Lundy, who resigned WIR Staff...
BioCentury | Mar 15, 2010
Clinical News

MRSA/MSSA blood culture test regulatory update

...MicroPhage submitted a 510(k) application to FDA for its Microphage MRSA/MSSA blood culture test to identify...
...cases of bacteremia. The test, which uses MicroPhage's bacteriophage amplification platform, is already CE marked. Microphage Inc....
BioCentury | Dec 14, 2009
Clinical News

MRSA/MSSA blood culture test regulatory update

...aureus bacteria and determine methicillin resistance (MRSA) or susceptibility (MSSA) in suspected cases of bacteremia. Microphage...
...of the test in August designed to support a 510(k) application (see BioCentury, Aug. 31). Microphage Inc....
BioCentury | Aug 31, 2009
Clinical News

MRSA/MSSA blood culture test: Pivotal trial started

...a U.S. pivotal trial to evaluate its MRSA/MSSA blood culture test in about 700 patients. Microphage Inc....
Items per page:
1 - 10 of 11